Every investor in Pfizer Inc. ( NYSE:PFE) should be aware of the most powerful shareholder groups. We can see that ...

Pfizer (NYSE: PFE) stock investors are curious about the valuation and prospects for the healthcare company. *Stock prices ...

PFE's strong economic moat is threatened by upcoming patent expirations, but its oncology segment shows promising growth ...

Range Financial Group LLC purchased a new stake in Pfizer Inc. (NYSE:PFE – Free Report) during the fourth quarter, according ...

Pfizer Inc. closed $4.65 short of its 52-week high ($31.54), which the company reached on July 30th.

At the same time, the expiration of key patents is coming up for some major Pfizer drugs, including blood thinner Eliquis and ...

Pfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.4% during trading on Wednesday . The stock traded as high as $26.65 and ...

These are companies with “wide economic moats” and “significant advantages” that allow them to successfully fend off ...

Pfizer on Thursday said it will raise its quarterly dividend by 2.4%. The New York-based drug company on Thursday said its board increased its cash dividend to 43 cents a share from 42 cents.

Shares in Pfizer listed on the New York Stock Exchange, fell 2% on Monday having lost 31% of their value over the previous 12 ...